Anti-ROR1 antibodies and uses thereof
US11932691B2 · kind B2 · utility
1Cited by
4References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2021 |
| Grant date | Mar 19, 2024 |
| Priority date | — |
| Expiry date | Dec 25, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70503
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to anti-ROR1 binding proteins, including those that bind to a ROR1 or portion thereof such as an intracellular C terminal portion of a ROR1 protein, and the use of such binding proteins in immunohistochemical and diagnostic methods. Related kits and methods of using the binding proteins are also provided, as are methods of treatment of subjects having diseases or conditions determined to be candidates for such treatments by the binding proteins or methods of this disclosure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.